Detalles de la búsqueda
1.
Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
CMAJ
; 192(23): E617-E625, 2020 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32538799
2.
Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
BMC Health Serv Res
; 16(a): 383, 2016 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27528247
3.
National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study.
BMJ Open
; 12(3): e055287, 2022 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264357
4.
Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature.
Health Policy
; 124(3): 231-238, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31926652
5.
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.
Health Policy
; 122(5): 509-518, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29605526
6.
Combating corruption in the pharmaceutical arena.
Indian J Med Ethics
; 3(3): 234-239, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550750
7.
Continuing medical education and pharmaceutical industry involvement: An evaluation of policies adopted by Canadian professional medical associations.
Int J Risk Saf Med
; 29(1-2): 1-16, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28885217
8.
Too few, too weak: conflict of interest policies at Canadian medical schools.
PLoS One
; 8(7): e68633, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23861928
9.
Combating corruption in the pharmaceutical arena
Indian J Med Ethics
; 2018 JUL; 3(3): 234
Artículo
| IMSEAR | ID: sea-195114
10.
Regulatory data are hidden in plain sight.
BMJ
; 358: j3437, 2017 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28724516
Resultados
1 -
10
de 10
1
Próxima >
>>